Search Result "BCR-ABL"


Research Article

BCR-ABL Transcript Level as Compared to LDH and Uric Acid Among Chronic Myeloid Leukemic Patients

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 16 Issue: 0 Year: 2021 Page: 1-11
Author(s): Temesgen Sisay Hailemariam,Mohammed Mehdi,Samuel Kinde,Daniel Seifu,Abebe Edao

Research Article

Effective Downregulation of BCR-ABL Tumorigenicity by RNA Targeted CRISPR-Cas13a

Journal: Current Gene Therapy
Volume: 21 Issue: 3 Year: 2021 Page: 270-277
Author(s): Aditya Singh,Prateek Bhatia

Review Article

Unleashing the Guardian: The Targetable BCR-ABL/HAUSP/PML/PTEN Network in Chronic Myeloid Leukemia

Journal: Current Drug Targets
Volume: 18 Issue: 4 Year: 2017 Page: 389-395
Author(s): Alessandro Morotti,Davide Torti,Giovanna Carra,Cristina Panuzzo,Sabrina Crivellaro,Riccardo Taulli,Carmen Fava,Angelo Guerrasio,Giuseppe Saglio

Review Article

Development of a Predictive Pharmacophore Model and a 3D-QSAR Study for an in silico Screening of New Potent Bcr-Abl Kinase Inhibitors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2017 Page: 188-204
Author(s): Eleni Vrontaki,Georgia Melagraki,Stella Voskou,Marios S. Phylactides,Thomas Mavromoustakos,Marina Kleanthous,Antreas Afantitis

Research Article

Flavonoid Derivatives Targeting BCR-ABL Kinase: Semisynthesis, Molecular Dynamic Simulations and Enzymatic Inhibition

Journal: Current Topics in Medicinal Chemistry
Volume: 21 Issue: 0 Year: 2021 Page: 1-19
Author(s): Rayssa Ribeiro,Mariana Alves Eloy,Carla Santana Francisco,Clara Lirian Javarini,Gabriela Miranda Ayusso,Victor Da Rocha Fonseca,Wanderson Romão,Luis Octavio Regasini,Sheila Cruz Araujo,Michell Oliveira Almeida,Kathia Maria Honorio,Heberth de Paula,Valdemar Lacerda Jr.,Pedro Alves Bezerra Morais

Basis for Resistance to Imatinib in 16 BCR-ABL Mutants as Determined Using Molecular Dynamics

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4 Issue: 2 Year: 2009 Page: 164-173
Author(s): Tai-Sung Lee, Steven J. Potts, Maher Albitar

The Emerging Role of Bcr-Abl-Induced Cystoskeletal Remodeling in Systemic Persistence of Leukemic Stem Cells

Journal: Current Drug Delivery
Volume: 11 Issue: 5 Year: 2014 Page: 582-591
Author(s): Adrian Bartos,Patrycja M. Dubielecka

Inhibition of PCAF by Anacardic Acid Derivative Leads to Apoptosis and Breaks Resistance to DNA Damage in BCR-ABL-expressing Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 5 Year: 2013 Page: 762-767
Author(s): Monika Kusio- Kobialka, Wioleta Dudka- Ruszkowska, Massimo Ghizzoni, Frank J. Dekker, Katarzyna Piwocka

New Opportunities to Treat the T315I-Bcr-Abl Mutant in Chronic Myeloid Leukaemia: Tyrosine Kinase Inhibitors and Molecules that Act by Alternative Mechanisms

Journal: Current Medicinal Chemistry
Volume: 17 Issue: 1 Year: 2010 Page: 1220-1245
Author(s): S. Schenone, C. Brullo, M. Botta

Tyrosine Kinases as Therapeutic Targets in BCR-ABL Negative Chronic Myeloproliferative Disorders

Journal: Current Drug Targets
Volume: 8 Issue: 2 Year: 2007 Page: 205-216
Author(s): Andreas Reiter, Christoph Walz, Nicholas C. P. Cross

Previous   Next

Go To   Results 11 - 20 of 1572

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy